City

Maastricht (1)

Singapore (1)

Condition

Leukemia (Both ALL and AML) (2)

Cancer of Lung (1)

MDS-EB-1 (1)

Myeloma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Maastricht University Medical Center (1)

Singapore Eye Research Institute (1)

Collaborator

Intervention

blood withdrawn (1)

cyclosporine ophthalmic (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

leukemia (both all and aml)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Changing Over Time of Ascorbic Acid After Chemotherapy

Active, not recruiting

Leukemia (Both ALL and AML)
+2 more

blood withdrawn

Maastricht, Limburg, Netherlands

MUMC+

Sep 23, 2021

Leukemia (Both ALL and AML), MDS-EB-1 Trial in Singapore (Cyclosporine Ophthalmic)

Recruiting

Leukemia (Both ALL and AML)
MDS-EB-1

Cyclosporine Ophthalmic

Singapore, Singapore

Singapore Eye Research Institute

Nov 14, 2020